Tango Therapeutics, Inc.
TNGX
Výsledovka
Rozvaha
Peněžní toky
Ukazatele
Klíčové metriky
V miliónech (USD)
| Revenue | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Revenues | 66.5 | 42.1 | 36.5 | 24.9 | 37.0 | 7.7 | |
| Cost of Revenues | 1.2 | 0.0 | 115.2 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 65.3 | 42.1 | -78.7 | 24.9 | 37.0 | 7.7 | |
| Operating Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 115.2 | 105.9 | 77.6 | 50.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 35.5 | 30.0 | 17.6 | 9.9 | |
| Depreciation & Amortization | 2.4 | 2.5 | 2.4 | 1.6 | 0.9 | 0.7 | |
| Total Operating Expenses | 175.7 | 187.7 | 150.7 | 135.9 | 95.2 | 59.9 | |
| Operating Income | -110.3 | -145.6 | -114.2 | -111.1 | -58.2 | -52.2 | |
| Net Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Interest Income | 5.8 | 7.9 | 6.6 | 1.5 | 0.5 | 0.1 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | -2.9 | 0.0 | 0.0 | |
| Other Expense | 9.9 | 15.5 | 12.6 | 2.9 | 0.2 | 0.2 | |
| IBT | -100.4 | -130.1 | -101.6 | -108.1 | -57.9 | -52.0 | |
| Income Tax Expense | 0.1 | 0.2 | 0.1 | 0.1 | 0.3 | -0.1 | |
| Net Income | -100.5 | -130.3 | -101.7 | -108.2 | -58.2 | -51.9 | |
| Per Share Data | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $-1.08 | $-1.23 | $-0.94 | $-0.59 | |
| EPS Diluted | $0.00 | $0.00 | $-1.08 | $-1.23 | $-0.94 | $-0.59 | |
| Shares Outstanding | 111.0 | 109.2 | 94.6 | 87.8 | 62.1 | 87.5 | |
| Diluted Shares Outstanding | 111.0 | 109.2 | 94.6 | 87.8 | 62.1 | 87.5 | |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 51.6 | 69.5 | 66.4 | 60.0 | 142.7 | 28.4 | |
| Short Term Investments | 270.5 | 188.4 | 270.5 | 306.2 | 342.5 | 161.9 | |
| Total Cash & ST Investments | 322.1 | 257.9 | 336.9 | 366.1 | 485.3 | 190.3 | |
| Accounts Receivable | 0.0 | 0.0 | 0.0 | 2.0 | 2.0 | 2.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.6 | 0.6 | 0.0 | |
| Other Current Assets | 6.3 | 8.4 | 9.7 | 6.6 | 4.5 | 1.3 | |
| Total Current Assets | 328.4 | 266.3 | 346.5 | 375.3 | 492.3 | 193.6 | |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 50.5 | 47.6 | 53.4 | 57.8 | 6.1 | 11.3 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.0 | 2.6 | 2.6 | 3.4 | 1.7 | 2.3 | |
| Total Long-Term Assets | 53.0 | 50.1 | 56.0 | 61.2 | 7.8 | 13.6 | |
| Total Assets | 381.5 | 316.5 | 402.6 | 436.5 | 500.2 | 207.3 | |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.1 | 1.6 | 2.8 | 4.5 | 3.2 | 1.8 | |
| Short-Term Debt | 2.4 | 2.5 | 2.1 | 1.8 | 1.5 | 1.0 | |
| Other Current Liabilities | 16.8 | 16.5 | 15.4 | 17.5 | 9.9 | 6.1 | |
| Current Liabilities | 43.9 | 38.2 | 45.9 | 55.5 | 40.7 | 40.9 | |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Long-Term Debt | 35.5 | 34.0 | 36.8 | 39.4 | 0.0 | 6.9 | |
| Capital Leases | 35.5 | 36.5 | 38.9 | 41.1 | 1.5 | 7.9 | |
| Def. Tax Liability | -54.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 133.8 | 117.0 | 149.5 | 187.0 | 155.4 | 168.7 | |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Retained Earnings | -434.7 | -501.6 | -371.3 | -269.5 | -161.3 | -103.1 | |
| Comprehensive Income | -0.3 | 0.3 | 0.2 | -3.7 | -0.8 | 0.0 | |
| Total Common Equity | 247.7 | 199.5 | 253.1 | 249.5 | 344.7 | 38.6 | |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Income | -116.5 | -130.3 | -101.7 | -108.2 | -58.2 | -52.0 | |
| Depreciation & Amortization | 2.5 | 2.5 | 2.4 | 1.6 | 0.9 | 0.7 | |
| Stock-Based Compensation | 24.0 | 28.9 | 19.1 | 14.2 | 7.8 | 1.8 | |
| Change Working Capital | -29.6 | -31.7 | -38.0 | -18.5 | -11.3 | 118.7 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 2.0 | 0.0 | 0.0 | -2.0 | |
| Change In Accounts Payable | -3.8 | -1.2 | -1.7 | 1.1 | 1.2 | 1.2 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | |
| Other Non-cash Items | 19.7 | -0.8 | 0.2 | 1.8 | 1.3 | 0.9 | |
| Cash from Operations | -120.1 | 0.0 | -118.0 | -109.1 | -59.5 | 70.1 | |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.8 | -0.8 | -1.5 | -7.7 | -1.8 | -1.1 | |
| Acquisitions | 22.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -376.1 | -240.9 | -310.6 | -208.5 | -372.4 | -207.5 | |
| Sales of Investment | 355.6 | 327.8 | 353.5 | 242.6 | 190.8 | 63.2 | |
| Other Investing Activities | -20.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -21.3 | 0.0 | 41.4 | 26.4 | -183.4 | -145.5 | |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | -2.1 | -2.4 | -2.2 | 39.6 | -6.4 | 7.9 | |
| Issuance of Common Stock | 125.6 | 0.0 | 80.0 | 1.6 | 30.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 44.7 | 0.0 | 2.4 | 0.0 | 327.3 | 0.0 | |
| Cash from Financing | 126.0 | 0.0 | 82.4 | 1.6 | 357.3 | 80.9 | |
| Free Cash Flow | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -120.8 | -132.3 | -119.5 | -116.8 | -61.4 | 69.0 | |
| Real Free Cash Flow | -144.8 | -161.2 | -138.6 | -131.0 | -69.2 | 67.2 | |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
